Strs Ohio Purchases Shares of 19,250 Cardinal Health, Inc. $CAH

Key Points

• Strs Ohio recently acquired a new position in Cardinal Health, purchasing 19,250 shares valued at approximately $2.65 million.
• Insider sales included significant transactions by CEO Stephen M. Mason and Jessica L. Mayer, with total insider sales amounting to $40.5 million in the last quarter.
• Cardinal Health announced a quarterly dividend of $0.5107 per share, representing an annualized yield of 1.4%, with the payment date set for October 15.

Strs Ohio purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 19,250 shares of the company's stock, valued at approximately $2,652,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of CAH. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock worth $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Cardinal Health by 17,589.1% during the 1st quarter. GAMMA Investing LLC now owns 964,941 shares of the company's stock worth $132,940,000 after acquiring an additional 959,486 shares during the last quarter. Zurich Insurance Group Ltd FI lifted its stake in shares of Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock worth $130,434,000 after acquiring an additional 927,950 shares during the last quarter. Finally, Nuveen LLC bought a new stake in shares of Cardinal Health during the 1st quarter worth approximately $106,065,000. 87.17% of the stock is owned by institutional investors.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares of the company's stock, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 in the last quarter. 0.09% of the stock is owned by insiders.

Cardinal Health Price Performance

Shares of CAH stock opened at $150.45 on Tuesday. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44. The stock's fifty day moving average price is $154.16 and its 200 day moving average price is $148.08. The company has a market cap of $35.93 billion, a price-to-earnings ratio of 23.33, a price-to-earnings-growth ratio of 1.29 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the previous year, the business earned $1.84 EPS. The firm's revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health's payout ratio is currently 31.63%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CAH. Argus set a $189.00 price target on Cardinal Health in a research note on Friday, August 22nd. UBS Group reissued a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Robert W. Baird raised their price objective on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a report on Tuesday, August 12th. Finally, Bank of America raised their price objective on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.